Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for DNAG stock. Download DNAG report.
Research Report
Get the full report for FREE
Date:Aug 13, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download DNAG report
  
Example preview: Research report for Dnaprint Genomics (DNAG) Research report for Dnaprint Genomics (DNAG) Research report for Dnaprint Genomics (DNAG) Research report for Dnaprint Genomics (DNAG)
   

Cash Flow for Dnaprint Genomics (DNAG)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
Symbol:  | Recent Quotes powered by
  quotemedia.com
Cash Flow for Dnaprint Genomics Inc.  (DNAG) 
$ 0.0005   -0.0001 (-16.67%) Volume: 100.25 k 3:51 PM EST Nov 6, 2009
Statement: View:
Cash Flow in Thousands of Dollars
12/2006 12/2005 12/2004 12/2003 12/2002
Net Income (12,348) (8,716) (3,735) (7,790) (3,114)
Depreciation & Amortization 403 224 183 126 179
Deferred Income Taxes - - - - -
Operating Losses 469 3,647 27 5,135 688
Extraordinary Losses - - - - -
Decrease in Receivables 27 (11) (34) 2 (23)
Decrease in Inventories 202 (223) (65) - -
Decrease in Other Current Assets - - - - -
Increase in Payables 2,035 778 (967) - 418
Increase in Other Current Liabilities - - - 1,536 -
Decrease in Other Working Capital - - - - -
Other Non-Cash Items 2,694 - - - -
Net Cash from Continuing Operations (5,782) (3,606) (3,764) (1,530) (1,571)
Net Cash from Discontinued Operations - - - - -
Cash from Operating Activities (5,782) (3,606) (3,764) (1,530) (1,571)
Sale of Property, Plant, Equipment - - - - 10
Sale of Short Term Investments - - - - -
Purchase of Property, Plant, Equipment (391) (124) (57) (14) (16)
Acquisitions 555 - - - -
Purchase of Short Term Investments - - - - -
Other Investment Changes, Net - 202 (194) - -
Cash from Investing Activities 163 (2,196) (251) (14) (6)
Issuance of Debt 4,716 4,103 - 732 1,255
Issuance of Capital Stock 3,034 4,463 4,621 906 296
Repayment of Debt (3,344) (1,801) (149) (78) (90)
Repurchase of Capital Stock - (135) - - -
Payment of Cash Dividends - - - - -
Other Financing Charges, Net - - 255 238 85
Cash from Financing Activities 4,405 6,630 4,728 1,798 1,547
Effect of Exchange Rate Changes 1 (0) - - -
Net Change in Cash (1,212) 828 713 254 (31)
Cash at Beginning of Year 1,807 979 266 12 43
Cash at End of Period 595 1,807 979 266 12

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, financials by Morningstar.  Terms of Use. 
   
 
Home > Companies > Dnaprint Genomics